Decreased analgesic requirement in recipient of liver transplantation from monozygotic twin - A case report -

Background There have been many reports about decreased analgesic requirements in liver transplant recipients compared with patients undergoing other abdominal surgery. Case Herein we describe a case in which a 42-year-old man underwent living donor liver transplantation from his monozygotic twin. Because innate pain thresholds may be similar in monozygotic twins, we could effectively investigate postoperative pain in the donor and the recipient. Concordant with previous reports, the recipient used less analgesic than the donor in the present study. Conclusions Physicians caring for patients who have received liver transplantation should consider their comparatively low requirement for analgesic, to prevent delayed recovery due to excessive use of analgesic.

[1]  T. Shine,et al.  Analgesic considerations for liver transplantation patients. , 2015, Current clinical pharmacology.

[2]  A. Concejero,et al.  Comparison of postoperative morphine requirements in healthy living liver donors, patients with hepatocellular carcinoma undergoing partial hepatectomy, and liver transplant recipients. , 2010, Transplantation proceedings.

[3]  J. Joh,et al.  Intrathecal morphine combined with intravenous patient‐controlled analgesia is an effective and safe method for immediate postoperative pain control in live liver donors , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  J. Tuttle-Newhall,et al.  Orthotopic liver transplant patients require less postoperative morphine than do patients undergoing hepatic resection. , 2002, Journal of clinical anesthesia.

[5]  D. Lezotte,et al.  Reduced use of intensive care after liver transplantation: Patient attributes that determine early transfer to surgical wards , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  D. Lezotte,et al.  Reduced use of intensive care after liver transplantation: Influence of early extubation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  W. T. Franks,et al.  Decreased patient analgesic requirements after liver transplantation and associated neuropeptide levels. , 1997, Transplantation.

[8]  J. Bourdarias,et al.  Incidence of tricuspid regurgitation and vena caval backward flow in mechanically ventilated patients. A color Doppler and contrast echocardiographic study. , 1995, Chest.

[9]  C. Stein,et al.  Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Misawa,et al.  Effect of cyclosporine A on the morphine-induced place preference , 1993, Neuroscience Letters.

[11]  O. Wolkowitz,et al.  Prednisone effects on neurochemistry and behavior. Preliminary findings. , 1990, Archives of general psychiatry.

[12]  D. R. Danielson,et al.  Comparison of analgesic requirements after liver transplantation and cholecystectomy. , 1989, Mayo Clinic proceedings.

[13]  P. Schoeffler,et al.  Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. , 1982, British journal of anaesthesia.

[14]  Grant R. Wilkinson,et al.  A physiological approach to hepatic drug clearance , 1975 .

[15]  G R Wilkinson,et al.  Commentary: a physiological approach to hepatic drug clearance. , 1975, Clinical pharmacology and therapeutics.